Advertisement
Advertisement
EOLS
Evolus, Inc. Common Stock
7.57
USDSponsored
-0.02
-0.26%
Aug 10, 15:59 UTC -4
Closed
After-Market
7.58
0.00
+0.07%
EOLS Earnings Reports
Positive Surprise Ratio
EOLS beat 22 of 35 last estimates.
63%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$79.58M
/-$0.06
Implied change from Q2 26 (Revenue/ EPS)
-5.35%
/-400.00%
Implied change from Q3 25 (Revenue/ EPS)
+15.40%
/-45.45%
Evolus, Inc. Common Stock earnings per share and revenue
On Aug 05, 2026, EOLS reported earnings of 0.02 USD per share (EPS) for Q2 26, beating the estimate of -0.03 USD, resulting in a 156.82% surprise. Revenue reached 84.08 million, compared to an expected 83.24 million, with a 1.02% difference. The market reacted with a +19.90% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 79.58 million USD, implying an decrease of -400.00% EPS, and decrease of -5.35% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
-$2.10
Surprise
-3,386.38%
QuidelOrtho Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
$0.13
Surprise
+374.26%
CeriBell, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.48
Actual
-$0.51
Surprise
-6.10%
Varex Imaging Corporation Common Stock
Report Date
Aug 10, 2026 For Q3 26
Estimate
$0.21
Actual
$0.31
Surprise
+44.93%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.03
Surprise
+74.05%
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
Accendra Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.19
Surprise
-113.00%
Quanterix Corporation Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.46
Actual
-$0.45
Surprise
+4.09%
Biote Corp. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.04
Actual
-$0.21
Surprise
-614.71%
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
FAQ
What were Evolus, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Evolus, Inc. Common Stock reported EPS of $0.02, beating estimates by 156.82%, and revenue of $84.08M, 1.02% above expectations.
How did the market react to Evolus, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 19.9%, changed from $6.18 before the earnings release to $7.41 the day after.
When is Evolus, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for Evolus, Inc. Common Stock's next earnings report?
Based on 5
analysts, Evolus, Inc. Common Stock is expected to report EPS of -$0.06 and revenue of $79.58M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement